Laser Therapy in the Complex Prevention and Treatment of Covid-19 (Preliminary Results)

Proceedings of 35^th World Congress on Heart Diseases & 33^rd World Congress on Cardiology & Heart Diseases

August 23-24,2021 | Webinar

V.A. Mikhaylov, M.D., Ph.D

Eternity Medicine Institute, Dubai

Keynote: J Cardiovasc Dis Diagn

Abstract :

This article presents preliminary results of treatment of 51 patients with COVID 19 (Moscow Region, Russia). These patients were subjected to various schemes of immune stimulation for the prevention and treatment of this disease. Were compared-Percutaneus laser therapy (PLT), Intravenous Laser Blood Irradiation (ILBI), Drug stimulation and their combination. The results showed: 1. In the treatment of COVID-19, the use of various types of immunomodulation and anticoagulants proved to be most effective. 2. The combination of ILBI and TLT with immunomodulators proved to be the most effective in the prevention and treatment of COVID-19. 3. Immediate use of immunomodulators at the very beginning of COVID-19 reduces the severity of the disease, and facilitates its course.